盆腔输卵管因素不孕患者IVF/ICSI助孕结局的影响因素分析
Analysis of Influencing Factors of IVF/ICSI Assisted Pregnancy Outcomes in Patients with Pelvic Tubal Infertility
摘要: 目的:分析盆腔输卵管因素不孕患者首次体外受精/卵胞浆内单精子注射(IVF/ICSI)助孕结局的影响因素。方法:回顾性收集2024年1月至2025年12月于马鞍山市妇幼保健院生殖医学中心首次接受IVF/ICSI治疗的187例盆腔输卵管因素不孕患者的临床资料。根据移植后是否获得临床妊娠将患者分为妊娠组(n = 49)与未妊娠组(n = 138),采用Mann-Whitney U检验比较两组间卵泡刺激素(FSH)、黄体生成素(LH)、雌二醇(E2)、孕酮(P)、催乳素(PRL)以及抗苗勒管激素(AMH)的水平差异,并通过二元Logistic回归分析影响临床妊娠结局的相关因素。结果:单因素分析显示,妊娠组年龄、不孕年限及FSH水平均低于未妊娠组,AMH水平高于未妊娠组,差异均有统计学意义(P < 0.05)。多因素Logistic回归分析显示,年龄、FSH水平和AMH水平均为临床妊娠的独立影响因素,差异有统计学意义(P < 0.05)。结论:对于盆腔输卵管因素不孕患者,年龄、FSH水平是IVF/ICSI助孕结局的风险因素,AMH水平则是IVF/ICSI助孕结局的保护因素,临床可围绕上述指标开展个体化预后评估和治疗决策。
Abstract: Objective: To analyze the influencing factors on the outcome of first in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) assisted pregnancy in patients with pelvic tubal infertility. Methods: A retrospective collection of clinical data was conducted on 187 patients with pelvic tubal infertility who received IVF/ICSI treatment for the first time at the Reproductive Medicine Center of Ma’anshan Maternal and Child Health Hospital from January 2024 to December 2025. According to whether clinical pregnancy was obtained after transplantation, patients were divided into a pregnant group (n = 49) and a non-pregnant group (n = 138). Mann-Whitney U test was used to compare the differences in levels of follicle stimulating hormone (FSH), luteinizing hormone (LH), estradiol (E2), progesterone (P), prolactin (PRL), and anti-Mullerian hormone (AMH) between the two groups, and binary logistic regression was used to analyze the relevant factors affecting clinical pregnancy outcomes. Results: Single factor analysis showed that the age, duration of infertility, and FSH levels in the pregnant group were lower than those in the non-pregnant group, while the AMH level was higher than that in the non-pregnant group, and the differences were statistically significant (P < 0.05). Multivariate logistic regression analysis showed that age, FSH level, and AMH level were independent influencing factors for clinical pregnancy, and the differences were statistically significant (P < 0.05). Conclusion: For patients with pelvic tubal infertility, age and FSH level are risk factors for IVF/ICSI assisted reproductive outcomes, while AMH level is a protective factor for IVF/ICSI assisted reproductive outcomes. Individualized prognosis assessment and treatment decisions can be made based on these indicators in clinical practice.
文章引用:袁碧柔, 潘维君. 盆腔输卵管因素不孕患者IVF/ICSI助孕结局的影响因素分析[J]. 临床医学进展, 2026, 16(8): 616-622. https://doi.org/10.12677/acm.2026.1682833

参考文献

[1] Li, X., Dong, L., Yong, S. and Wei, H. (2014) Reproductive Outcomes after Operative Laparoscopy of Patients with Tubal Infertility with or without Hydrosalpinx. Chinese Medical Journal, 127, 593-594.
https://doi.org/10.3760/cma.j.issn.0366-6999.20131942
[2] 林小娜, 黄国宁, 孙海翔, 等. 输卵管性不孕诊治的中国专家共识[J]. 生殖医学杂志, 2018, 27(11): 1048-1056.
[3] Honoré, G.M., Holden, A.E.C. and Schenken, R.S. (1999) Pathophysiology and Management of Proximal Tubal Blockage. Fertility and Sterility, 71, 785-795.
https://doi.org/10.1016/s0015-0282(99)00014-x
[4] Wang, Y., Li, R., Yang, R., Zheng, D., Zeng, L., Lian, Y., et al. (2024) Intracytoplasmic Sperm Injection versus Conventional In-Vitro Fertilisation for Couples with Infertility with Non-Severe Male Factor: A Multicentre, Open-Label, Randomised Controlled Trial. The Lancet, 403, 924-934.
https://doi.org/10.1016/s0140-6736(23)02416-9
[5] Boulet, S.L., Mehta, A., Kissin, D.M., Warner, L., Kawwass, J.F. and Jamieson, D.J. (2015) Trends in Use of and Reproductive Outcomes Associated with Intracytoplasmic Sperm Injection. The Journal of the American Medical Association, 313, 255-263.
https://doi.org/10.1001/jama.2014.17985
[6] Esteves, S.C. and Humaidan, P. (2024) Conventional In-Vitro Fertilisation versus Intracytoplasmic Sperm Injection for Male Infertility. The Lancet, 403, 880-881.
https://doi.org/10.1016/s0140-6736(23)02583-7
[7] 何敏, 贾俊龙, 闫茜起, 等. IVF-ET助孕临床妊娠结局的影响因素分析[J]. 西北国防医学杂志, 2021, 42(6): 489-493.
[8] 凌琳, 叶平, 胡蓝雅文. 卵巢储备功能评估指标的研究进展[J]. 浙江医学, 2018, 40(21): 2394-2396.
[9] 贺桂珍, 万晓慧. 评估卵巢反应性指标的研究进展[J]. 临床医学进展, 2023, 13(3): 3556-3561.
[10] 陈丽华, 高凤霞, 孙爱军. 卵巢储备功能评价的研究进展[J]. 生殖医学杂志, 2014, 23(4): 330-333.
[11] Broekmans, F.J., Kwee, J., Hendriks, D.J., Mol, B.W. and Lambalk, C.B. (2006) A Systematic Review of Tests Predicting Ovarian Reserve and IVF Outcome. Human Reproduction Update, 12, 685-718.
https://doi.org/10.1093/humupd/dml034
[12] 卜晓萌, 刘艳君, 周丽颖, 等. 卵巢储备正常不孕女性低获卵数的高危因素分析[J]. 生殖医学杂志, 2022, 31(6): 777-781.
[13] 叶静, 陈秋菊, 匡延平. 卵巢功能正常患者高孕激素状态下促排卵的内分泌特征及IVF/ICSI临床结局的研究[J]. 中华生殖与避孕杂志, 2015, 35(6): 393-400.
[14] 涂彬彬, 张珺, 赵捷, 等. 高龄和年轻女性宫腔内人工授精临床妊娠结局影响因素分析[J]. 中华妇产科杂志, 2026, 61(3): 195-202.
[15] Nesbit, C.B., Blanchette-Porter, M. and Esfandiari, N. (2022) Ovulation Induction and Intrauterine Insemination in Women of Advanced Reproductive Age: A Systematic Review of the Literature. Journal of Assisted Reproduction and Genetics, 39, 1445-1491.
https://doi.org/10.1007/s10815-022-02551-8
[16] McPherson, N.O., Vincent, A.D., Pacella-Ince, L. and Tremellen, K. (2021) Comparison of in Vitro Fertilisation/Intracytoplasmic Sperm Injection on Live Birth Rates in Couples with Non-Male Factor Infertility and Advanced Maternal Age. Journal of Assisted Reproduction and Genetics, 38, 669-678.
https://doi.org/10.1007/s10815-020-02026-8
[17] 王大琳, 范东青, 陈芳, 等. 辅助生殖中预测卵巢反应性指标的探讨[J]. 中国生育健康杂志, 2019, 30(2): 172-176.
[18] 杨丽, 王雪松, 姜佳佳, 等. 抗苗勒管激素低水平人群行IVF/ICSI助孕效果分析[J]. 生殖医学杂志, 2025, 34(1): 36-42.
[19] 中国遗传学会遗传咨询分会, 中国医师协会医学遗传医师分会生殖遗传学组, 出生缺陷防控协同创新共同体, 等. 胚胎植入前遗传学检测的遗传咨询专家共识[J]. 中华妇产科杂志, 2024, 59(12): 899-909.
[20] 程德华, 谢平原, 胡晓, 等. 胚胎植入前遗传学检测技术的临床应用和发展前景[J]. 实用妇产科杂志, 2023, 39(3): 167-171.